|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Thorac Cardiovasc Surg 1999;117:1046
© 1999 Mosby, Inc.
LETTERS TO THE EDITOR |
Department of Surgery
Stanford University Hospital
Room H3680
300 Pasteur Dr
Stanford, CA 94305
Reply to the Editor
We thank Dr Gu and his colleagues for their interest in our recent article.
1 They describe a prospective study in 60 patients in whom cardiopulmonary bypass (CPB) was used, but did not mention where these results have been published. They did not find a correlation between PO2 on CPB and neutrophil elastase release. However, there are several methodologic differences between our two studies. First, they wrote, "a large variation in PO2 appeared during perfusion," and their results showed that PO2 varied between 107 and 440 mm Hg at the start of cooling, between 80 and 308 mm Hg during hypothermia, and between 128 and 317 mm Hg on average during CPB. It is not clear whether these disparities in PO2 occurred randomly and within the same patient. Further, it is not evident whether normoxia was maintained at all times, as it was done in our study. This seems very important, because we also did not find a positive correlation between PO2 and elastase at the beginning of CPB with low elastase levels, but when PO2 was controlled to normoxic levels during the whole period of extracorporeal circulation, elastase release was reduced significantly compared with high levels after persistent hyperoxia. Second, they measured PO2 levels only 5 times during CPB: PO2 between these measurements is unknown and might have reached undesired levels. In our study, on-line PO2 measurements were applied and the PO2 during CPB was controlled at all times. Third, different types of oxygenators were used during their study. These differences might have influenced results, as our data (unpublished) indicate, namely, that elastase release varies between oxygenators. Fourth, blood samples in their study were obtained from the radial artery, whereas our blood samples were taken from coronary sinus blood and from the venous side of the CPB circuit. The significance of this detail, and whether this might have influenced results, however, remains unknown.
The authors mention that "elastase release during CPB has been known to be largely attributed to blood interaction with the artificial surface of the extracorporeal circuit."
2,3 These results confirm (as mentioned above) our own findings, in which membrane oxygenators cause less oxidative damage than bubble oxygenators. In their explanation, the authors reason: "It could well be that normoxic CPB had reduced the cardiac source of elastase but that the effect had been systematically counteracted by other factors, such as blood-material interaction." This statement is in contrast to our findings, in which values from coronary sinus blood and systemic circulation were not different and improved after normoxia. Independently from reduced leukocyte elastase levels, there are additional benefits from normoxic CPB.
4,5
In summary, there are considerable methodologic differences between their study and ours. Our protocol of controlled normoxic CPB for the first time establishes a correlation between PO2 and leukocyte elastase, whereas their investigation of "a large variation in PO2" could not confirm this finding. I do agree with their conclusion that further studies are necessary to address this issue. Furthermore, the clinical significance of reduced leukocyte elastase after normoxic CPB has to be established.
12/8/96852
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |